FBIOX : FIDELITY SELECT BIOTECHNOLOGY

 
 
3
 
 

ZACKS RANK: 3 - HOLD

Ticker: FBIOX
Manager: Rajiv Kaul
Manager Since: 10/05
NAV (07/28/2014): 196.40
Objective: Health Care - Equity
Peer: HL MG
Net Assets ($mil): 8129.80
Inception: 12/16/1985
FBIOX : Description

Incepted in December 1985 and managed by the Fidelity Group, the objective of this fund is to seek capital appreciation. It normally invests at least 80% of assets in common stocks of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. The fund offers dividends and capital gains in the month of April and December.

FBIOX : Composition - 07/14
Stocks 99.21%
Foreign Stocks 1.59%
Cash 7.33%
Bonds 0.00%
Foreign Bonds 0.00%
Preferred 0.04%
Convertible 0.30%
Other -6.89%
Foreign Hedged 0.00%
Composition Horizontal Bar Chart
FBIOX : Style Analysis - 07/14
Large Growth 28.15%
Large Value 0.00%
Small Growth 8.37%
Small Value 0.00%
Foreign Stock 28.15%
Emerging Market 0.00%
Precious Metals 0.00%
Intermediate Bond 26.26%
High Yield Bond 0.00%
Foreign Bond 0.00%
Style Analysis Horizontal Bar Chart
FBIOX : Risk Analysis
Beta v. S&P 500 1.05
Beta v. EAFE -0.04
Beta v. Barclays Agg Bond 1.14
Alpha 3 Yr 19.43
Alpha 5 Yr 10.17
R-Sq 3 Yr 0.28
R-Sq 5 Yr 0.40
Std Dev 3 Yr 21.57
Std Dev 5 Yr 21.14
Sharpe 3 Yr 1.78
Sharpe 5 Yr 1.49
FBIOX : Fees
Expense Ratio 0.76
% Max Load NA
% Min Load NA
% Deferred Load NA
% Redemption 0.75
% Max 12 B1 Fee 0.00
% Max Mgt Fee 0.55
FBIOX : Purchase Choices:
Min Initial Investment 2500
Min Subsequent Investment 0
FBIOX : Returns Analysis - Annual

Line chart

  2004200520062007200820092010201120122013YTD
NAV ($) 57.6562.7064.9666.6859.1165.4972.9686.10109.99181.73196.40
Total Return (%) 11.988.763.602.64-11.3510.7911.4018.1836.5965.6610.20
Annual Dividend Yield (%) 0.000.000.000.000.000.000.000.000.000.000.00
Relative Performance
Rel Performance-S&P500(%) 11.1238.69-121.92-28.47256.55-156.28-36.58160.82205.98332.8330.92
Rel Performance-Obj.Ret.(%) 32.05-2.03-1.31-62.17123.44-110.8433.81104.33173.59193.57-13.70
Ret.Quintile vs Obj(1 is best) 24351521114
Turnover, Yields, and Gains
Fund Assets Net($mil) 1,8501,6791,4641,1881,1971,0511,0381,3412,7317,9598,130
Annual Turnover (%) 29.0019.0063.0070.00143.0055.00109.00119.00106.0042.0035.00
Annual Dividend Paid ($) 0.000.000.000.000.000.000.000.000.000.000.00
Annual Capital Gains Paid($) 0.000.000.000.000.000.000.000.126.480.460.00
FBIOX : Returns Analysis - Trailing Total Return
  1 Month 3 Month 6 Month YTD 1 Year 3 Year 5 Year 10 Year 15 Year 20 Year
Total Return (through 07/14) 7.40% 2.78% 10.20% 10.20% 41.61% 35.49% 28.90% 13.85% 11.61% 14.13%
Ret. Percentile vs. Obj. (1 is best) 15 87 69 69 15 2 3 11 26 23
FBIOX : Stock Portfolio Snapshot - 07/14
Average Price/Earnings 41.60
Average Price/Book 5.68
Average EPS Growth 15.50
Average Market Value 42,088.00
FBIOX : Stock Sector Breakout - 07/14
Stock Sector Breakout
FBIOX : Top Holdings - 07/14
Name Weight Shares
GILEAD SCIENCES INC 13.34 17,774,703
AMGEN INC 9.16 8,147,681
BIOGEN IDEC INC 6.70 2,168,789
~INTERCEPT PHARMACEUTICALS IN 4.89 1,315,567
BIOMARIN PHARMACEUTICAL 1.68 2,294,144
CELGENE CORP 4.19 2,875,102
REGENERON PHARMACEUTICALS 3.81 1,262,849
VERTEX PHARMACEUTICALS INC 2.99 4,075,800
ALEXION PHARMACEUTICALS INC 4.46 2,781,842